Delivery Order SPE2DB20D3103-SPE2DB24FN4H2
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,191.40 fixed-price delivery order is for the supply of Biktarvy 50-200-25 mg tablets, a specialty medication. The contract has a completion date of November 20, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Biktarvy 50-200-25 mg tablets. The $29,476.02 firm fixed-price delivery order has a completion date of July 20, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary vehicle for the company to provide a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $37,074.75 firm-fixed-price delivery order is for the supply of Biktarvy 50-200-25 mg tablets, a prescription medication, to support the Department of Defense (DoD) and other government agencies. The award is not associated with a set-aside program. AmerisourceBergen, as a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $38,888.67 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of Biktarvy 50-200-25 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $29,558.37, is for the delivery of Biktarvy 50-200-25 mg tablet medication under a Firm Fixed Price Delivery Order contract. The contract has a completion date of May 13, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $78,159.94, is a delivery order for Biktarvy 50-200-25 mg tablets. The contract has an ultimate completion date of December 5, 2024 and is a firm fixed price contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award, valued at $51,492.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the procurement of BIKTARVY 50-200-25 MG TABLET, a specialty medication, to support federal healthcare programs. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $22,982.83 delivery order covers the supply of Biktarvy 50-200-25 30S, a prescription medication, to support military healthcare programs. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,022.25 delivery order contract is for the supply of Biktarvy 50-200-25 mg tablets, a prescription medication, with a period of performance through April 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,621.51 Firm Fixed Price Delivery Order contract is for the supply of Biktarvy 50-200-25 mg tablets, a pharmaceutical product used in the treatment of HIV/AIDS. The contract has an ultimate completion date of July 2, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FN4H2Delivery Order
This federal contract award, valued at $82,322.33, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of Biktarvy 50-200-25 mg tablets, a specialty medication, to support military and government healthcare programs. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to the Department of Defense worldwide. This contract award does not have a set-aside designation, indicating open competition. Additionally, AmerisourceBergen's parent company, Cencora, Inc., maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs. These IDCs demonstrate AmerisourceBergen's extensive experience and capacity to meet the diverse pharmaceutical needs of multiple government agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $82.3k | 4/15/24 |